CD8A and neoplasm: In addition, the prevalence of focal CD8+ T cell aggregates within tumor tissues was also increased after BCG treatment; they were observed only in 4 (20%) of 20 patients before BCG, but were more frequently observed after BCG treatment [10 (50%) of 20 patients] (Table 3).